The Danish company stopped deliveries to Russian Federation a preparation from diabetes

The Danish Novo Nordisk stopped deliveries to Russian Federation a preparation from diabetes "Ozempik" the Danish company Novo Nordisk ceased to deliver to freepik to Russian Federation a popular preparation from diabetes "Ozempik" (semaglutid), reported daily business newspaper "RBK daily" in Federal Service for Supervision in the Sphere of Health Care . There specified that received the notice of such intention even in the fall of 2022. Representatives of department told that suppliers of medicines have to direct in advance similar notices, and the Danish company in this sense observed standards of the Russian legislation. Journalists asked experts of NMITs of endocrinology, whether the solution of Novo will affect...